Quarterly report pursuant to Section 13 or 15(d)

EMPLOYEE STOCK OPTIONS AND RESTRICTED STOCK AWARD PLAN

v3.20.1
EMPLOYEE STOCK OPTIONS AND RESTRICTED STOCK AWARD PLAN
3 Months Ended
Mar. 31, 2020
EMPLOYEE STOCK OPTIONS AND RESTRICTED STOCK AWARD PLAN  
EMPLOYEE STOCK OPTIONS, RESTRICTED STOCK AWARD PLAN AND 401(k)

NOTE 11 – EMPLOYEE STOCK OPTIONS AND RESTRICTED STOCK AWARD PLAN

Compensation expense charged against income for share-based awards during the three months ended March 31, 2020, was $673,795 as compared to $834,465 for the three months ended March 31, 2019. These amounts are included in general and administrative expense in the accompanying financial statements.

In 2011, the board of directors and stockholders approved and adopted a long-term incentive plan which allowed for the issuance of up to 2,500,000 shares of common stock through the grant of qualified stock options, non-qualified stock options and restricted stock. In 2013, the Company’s board of directors and stockholders approved an amendment to the long-term incentive plan, increasing the number of shares eligible under the plan to 5,000,000 shares. As of March 31, 2020, there were 31,355 shares remaining eligible for issuance under the plan.

Stock Options

A summary of the stock option activity as of March 31, 2019 and 2020, respectively, and changes during the three months then ended is as follows:

    

    

    

Weighted-

    

Weighted-

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Shares

Price

Term

Value

Outstanding, December 31, 2018

 

2,751,000

$

6.28

 

  

 

  

Granted

 

$

 

  

 

  

Forfeited or rescinded

 

(2,500)

$

11.70

 

  

 

  

Vested

 

$

 

  

 

  

Outstanding, March 31, 2019

 

2,748,500

$

6.28

 

5.3 Years

$

3,366,300

Exercisable, March 31, 2019

 

2,323,400

$

5.42

 

4.6 Years

 

  

Outstanding, December 31, 2019

 

2,748,500

$

6.28

 

  

 

  

Granted

 

$

 

  

 

  

Forfeited or rescinded

 

$

 

  

 

  

Vested

 

$

 

  

 

  

Outstanding, March 31, 2020

 

2,748,500

$

6.28

 

3.7 Years

$

Exercisable, March 31, 2020

 

2,506,700

$

5.78

 

3.4 Years

 

  

The intrinsic value was calculated using the closing price on March 31, 2019 and 2020 of $5.87 and $0.66, respectively. As of March 31, 2020, there was $575,402 of unrecognized compensation cost related to stock options that is expected be recognized over a weighted-average period of 1.3 years.

Restricted Stock

A summary of the restricted stock activity as of March 31, 2019 and 2020, and changes during the three months then ended is as follows:

    

    

Weighted- 

Average Grant  

Restricted stock

Date Fair Value

Outstanding, December 31, 2018

 

878,360

$

7.36

Granted

 

 

Forfeited or rescinded

 

(4,400)

 

7.53

Vested

 

 

Outstanding, March 31, 2019

 

873,960

$

7.36

Outstanding, December 31, 2019

 

1,341,889

$

4.94

Granted

 

 

Forfeited or rescinded

 

(2,400)

 

4.78

Vested

 

 

Outstanding, March 31, 2020

 

1,339,489

$

4.93

As of March 31, 2020, there was $3,905,640 of unrecognized compensation cost related to restricted stock grants that will be recognized over a weighted average period of 1.6 years.